stockrow
Saturday 7 November 2026
Export NMTC’s income statement to Excel — free account
NeuroOne Medical Technologies Corporation
NMTC Healthcare Medical Devices
NeuroOne Medical Technologies Corporation’s revenue for fiscal 2025 (year ended September 2025) was $9.1 million, up 163.5% from fiscal 2024.
- Revenue
- +16.3%
- EPS
- −27.8%
- Free cash flow
- +26.9%
Quarter to June 2026, against a year earlier
0.85
0.01
−1.16%
Follow NMTC
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
3 | 4 | 5 | 6 |
+8 more TTM periods Free account |
| (124.66%) | (223.76%) | (146.27%) | (91.34%) | ||
| (87.56%) | (115.42%) | (90.61%) | (44.63%) | ||
ROIC |
(287.08%) | (202.41%) | (168.23%) | (526.10%) | |
Return on Tangible Assets |
(188.51%) | (122.86%) | (96.81%) | (44.06%) | |
Average Days of Receivables |
42.36 | 75.35 | 111.47 | 50.74 | |
Free Cash Flow per Share |
(0.83) | (0.89) | (0.75) | (0.44) | |
Free Cash Flow |
(7.16) | (7.57) | (6.26) | (2.92) | |
Capital Expenditures |
(0.11) | (0.13) | (0.10) | (0.08) | |
| Other line items | |||||
Cash ROIC |
(123.15%) | (96.01%) | (62.82%) | (21.40%) | |
Accounts Receivable Turnover |
13.36 | 4.31 | 6.14 | 10.86 | |
Accounts Payable Turnover |
6.12 | 4.54 | 6.07 | 3.88 | |
Inventory Turnover |
2.01 | 2.13 | 2.19 | 1.63 | |
Average Days of Payables |
78.72 | 81.38 | 51.25 | 93.22 | |
Days of Inventory on Hand |
199.07 | 182.88 | 154.59 | 205.44 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
57.04% | 56.12% | 59.67% | 54.78% | |
Selling, General and Administrative Expense of Revenue |
82.04% | 78.39% | 82.91% | 81.17% | |
Share Based Compensation of Revenue |
14.92% | 14.98% | 14.74% | 13.90% | |
Operating CF/Net income |
0.95 | 1.07 | 0.90 | 0.79 | |
Depreciation/Fixed assets |
1.17 | 1.11 | 1.07 | 1.75 | |
Capex/Depreciation |
(0.46) | (0.52) | (0.37) | (0.18) | |
Revenue per Share |
1.09 | 1.08 | 1.04 | 1.36 | |
Operating CF per Share |
(0.81) | (0.88) | (0.73) | (0.42) | |
Capex per Share |
(0.01) | (0.02) | (0.01) | (0.01) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 |
Columns are period end dates · fundamentals updated 26 Oct 2026